Find in Library

P1552: A PHASE 2, OPEN-LABEL STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFECT OF ANX005 IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA AND EVIDENCE OF COMPLEMENT ACTIVATION

oleh: U. Jaeger, C. Broome, R. Go, A. Patriarca, A. Roeth, Q. Chang, N. Weedin, P. Adams, E. Cahir-McFarland, H.-A. Kroon